Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Edelman

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Current Treatment Options in Oncology|June 12, 2002
Advanced non-small cell lung cancerM J Edelman, S L Khanwani
Critical Reviews in Oncology/Hematology|July 3, 1998
Small cell lung cancer: current status of new chemotherapeutic agentsM J Edelman, D R Gandara
Archives of Internal Medicine|August 1, 1988
Severe cryptosporidiosis in an immunocompetent hostM J Edelman, E C Oldfield
The Western Journal of Medicine|July 10, 1998
Follow-up testing after cancer treatment: is it indicated?M J Edelman, D Siegel, F Meyers
Cancer Chemotherapy and Pharmacology|September 20, 2001
Interactions of gemcitabine, carboplatin and paclitaxel in molecularly defined non-small-cell lung cancer cell linesM J Edelman, H Quam, B Mullins
American Journal of Hematology|April 1, 1997
Treatment of refractory large granular lymphocytic leukemia with 2-chlorodeoxyadenosineM J Edelman, R T O'Donnell, I Meadows
Journal of General Internal Medicine|May 1, 1997
The utility of follow-up testing after curative cancer therapy. A critical review and economic analysisM J Edelman, F J Meyers, D Siegel
Seminars in Oncology|August 7, 1999
Emerging role of docetaxel (Taxotere) in advanced non-small cell lung cancerD R Gandara, M J Edelman, D Lau
The American Journal of Gastroenterology|January 1, 1977
Pneumatosis cystoides intestinalis presenting with hemoccult-positive stoolsD K Bhargava, M J Edelman, S J Winawer
Seminars in Oncology|November 5, 1997
Phase I trial of paclitaxel, carboplatin, and methotrexate with granulocyte colony-stimulating factor and leucovorin in advanced transitional cell carcinomaM J Edelman, F J Meyers, J Houston, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Current Treatment Options in Oncology|June 12, 2002
Advanced non-small cell lung cancerM J Edelman, S L Khanwani
Critical Reviews in Oncology/Hematology|July 3, 1998
Small cell lung cancer: current status of new chemotherapeutic agentsM J Edelman, D R Gandara
Archives of Internal Medicine|August 1, 1988
Severe cryptosporidiosis in an immunocompetent hostM J Edelman, E C Oldfield
The Western Journal of Medicine|July 10, 1998
Follow-up testing after cancer treatment: is it indicated?M J Edelman, D Siegel, F Meyers
Cancer Chemotherapy and Pharmacology|September 20, 2001
Interactions of gemcitabine, carboplatin and paclitaxel in molecularly defined non-small-cell lung cancer cell linesM J Edelman, H Quam, B Mullins
American Journal of Hematology|April 1, 1997
Treatment of refractory large granular lymphocytic leukemia with 2-chlorodeoxyadenosineM J Edelman, R T O'Donnell, I Meadows
Journal of General Internal Medicine|May 1, 1997
The utility of follow-up testing after curative cancer therapy. A critical review and economic analysisM J Edelman, F J Meyers, D Siegel
Seminars in Oncology|August 7, 1999
Emerging role of docetaxel (Taxotere) in advanced non-small cell lung cancerD R Gandara, M J Edelman, D Lau
The American Journal of Gastroenterology|January 1, 1977
Pneumatosis cystoides intestinalis presenting with hemoccult-positive stoolsD K Bhargava, M J Edelman, S J Winawer
Seminars in Oncology|November 5, 1997
Phase I trial of paclitaxel, carboplatin, and methotrexate with granulocyte colony-stimulating factor and leucovorin in advanced transitional cell carcinomaM J Edelman, F J Meyers, J Houston, et al.
Pageof 5